Joy Derwenskus, DO
Disclosures: Biogen Idec-Speakers Bureau-Presented at patient programs.-Tecfidera-Multiple Sclerosis-Option_2-Option_2-Possible it would be listed in addition to the other medications used to treat MS.|EMD Serono-Speakers Bureau-Presented at patient/peer programs.-Mavenclad-Multiple Sclerosis-Option_2-Option_2-Possible it would be listed in addition to the other medications used to treat MS.|Genentech, Inc.-Speakers Bureau-Speaker for patient/peer programs and consultant at advisory board.-Ocrevus-Multiple Sclerosis-Option_2-Option_2-Possible it would be listed in addition to the other medications used to treat MS.|Celgene-Consulting Fee-Consultant at advisory board.-Ozanimod-Multiple Sclerosis-Option_2-Option_1-Possible it would be listed in addition to the other medications used to treat MS, but would be discussed as an emerging therapy.|Genzyme Corporation-Speakers Bureau-Speaker for patient/peer programs.-Aubagio-Multiple Sclerosis-Option_2-Option_2-Possible it would be listed in addition to the other medications used to treat MS.|Novartis AG-Speakers Bureau-Attended speaker training. -Gilenya and Mayzent.-Multiple Sclerosis-Option_2-Option_2-Possible it would be listed in addition to the other medications used to treat MS|TEVA-Speakers Bureau-Speaker for peer programs.-Ajovy-Migraine headaches-Option_2-Option_2-Possible it would be listed in addition to the other medications used to treat migraines. (Last program done was on January 31, 2019)
No Bio Available.